Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Natalizumab, a humanized anti-α4 integrin monoclonal antibody, is a highly effective treatment approved for MS. An association between MS and an exposure to Epstein-Barr Virus (EBV) sustained by the l...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Dis Markers
Prif Awduron: Castellazzi, Massimiliano, Delbue, Serena, Elia, Francesca, Gastaldi, Matteo, Franciotta, Diego, Rizzo, Roberta, Bellini, Tiziana, Bergamaschi, Roberto, Granieri, Enrico, Fainardi, Enrico
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2015
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4460255/
https://ncbi.nlm.nih.gov/pubmed/26101453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/901312
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg